# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Uveal diseases

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 110 results.
Monitoring Drug-induced Uveitis
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Apr 02, 2019
Disease(s): Uveitis, Uveitis Drug-Induced, Eye Diseases, Uvea--Diseases
Intervention(s): Drugs inducing uveitis
Locations: AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM, Paris, France
Abatacept in Patients With Birdshot HLA A29 Uveitis
Status: Recruiting
Last Changed: Apr 16, 2019
First Received: Mar 12, 2019
Disease(s): Eye Diseases, Uveitis
Intervention(s): Abatacept 125 MG/ML Prefilled Syringe
Locations: UZLeuven, Leuven, Vlaams-Brabant, Belgium
Study of Changes in Retrofoveolar Choroidal Thickness During Aerobic Exercise
Status: Not yet recruiting
Last Changed: Apr 18, 2019
First Received: May 22, 2018
Disease(s): Choroid Disease, Hypertension Ocular
Intervention(s): Examination of pressures before stopping the exercise, Examination of pressure during the exercise, Examination of pressures after stopping the exercise
Locations: University Hospital Toulouse, Toulouse, France
Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response
Status: Recruiting
Last Changed: Apr 10, 2020
First Received: Dec 10, 2019
Disease(s): Uveitis
Intervention(s): Surveillance card
Locations: Department of Ophthalmology, Wrocław, Poland
Intestinal Bacteria and Ocular Inflammatory Disease
Status: Recruiting
Last Changed: Jun 09, 2020
First Received: May 21, 2013
Disease(s): Uveitis
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis
Status: Not yet recruiting
Last Changed: Apr 21, 2020
First Received: Apr 21, 2020
Disease(s): Non-Infectious Active Uveitis
Intervention(s): s-CD95-L
Locations: CHU Bordeaux, Bordeaux, France
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant
Status: Recruiting
Last Changed: Apr 09, 2020
First Received: Apr 09, 2020
Disease(s): Uveitis
Intervention(s): Fluocinolone Acetonide
Locations: Cole Eye Institute Cleveland Clinic Foundation, Cleveland, Ohio, United States
A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: Dec 23, 2019
Disease(s): Non-infectious Uveitis
Intervention(s): EYS606
Locations: Cleveland Clinic Foundation, Cleveland, Ohio, United States
Texas Retina Associates, Arlington, Texas, United States
Houston Eye Associates, Houston, Texas, United States
Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis
Status: Recruiting
Last Changed: Feb 10, 2020
First Received: Nov 14, 2019
Disease(s): Uveitis
Intervention(s): Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos
Locations: RSCM Kirana, Jakarta Pusat, DKI Jakarta, Indonesia
Medication Compliance in the Paediatric Uveitis Population Reported by the Patients and Parents
Status: Recruiting
Last Changed: Mar 17, 2020
First Received: Nov 01, 2019
Disease(s): Uveitis
Locations: Manchester Royal Eye Hospital, Manchester, United Kingdom